Signaturefd LLC decreased its position in shares of Chemed Co. (NYSE:CHE – Free Report) by 26.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 333 shares of the company’s stock after selling 121 shares during the quarter. Signaturefd LLC’s holdings in Chemed were worth $176,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of CHE. Pathstone Holdings LLC lifted its stake in shares of Chemed by 6.0% during the third quarter. Pathstone Holdings LLC now owns 3,694 shares of the company’s stock valued at $2,220,000 after buying an additional 210 shares during the period. B. Metzler seel. Sohn & Co. Holding AG purchased a new position in Chemed during the third quarter worth approximately $310,000. Commerce Bank raised its stake in Chemed by 0.6% during the third quarter. Commerce Bank now owns 6,207 shares of the company’s stock worth $3,730,000 after purchasing an additional 40 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Chemed during the third quarter worth approximately $3,835,000. Finally, Charles Schwab Investment Management Inc. raised its stake in Chemed by 8.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 122,788 shares of the company’s stock worth $73,792,000 after purchasing an additional 9,178 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have weighed in on CHE shares. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada increased their price target on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th.
Insider Transactions at Chemed
In other Chemed news, VP Brian C. Judkins acquired 145 shares of the company’s stock in a transaction dated Monday, December 30th. The stock was bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the transaction, the vice president now directly owns 1,678 shares of the company’s stock, valued at approximately $871,721. The trade was a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the sale, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at $60,957,441.93. The trade was a 1.91 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 3.32% of the company’s stock.
Chemed Stock Down 1.2 %
Chemed stock opened at $594.41 on Friday. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $648.29. The firm has a fifty day moving average of $567.72 and a 200-day moving average of $565.52. The firm has a market capitalization of $8.70 billion, a P/E ratio of 30.04, a PEG ratio of 2.15 and a beta of 0.43.
Chemed Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. The ex-dividend date was Monday, February 24th. Chemed’s payout ratio is currently 10.05%.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Stories
- Five stocks we like better than Chemed
- How to Read Stock Charts for Beginners
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Using the MarketBeat Dividend Tax Calculator
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Comparing and Trading High PE Ratio Stocks
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.